Longitudinal changes in quantitative EEG during long-term tacrine treatment of patients with Alzheimer's disease

Quantitative EEG is a potentially useful tool in demonstrating the effects of treatments with acetylcholinesterase (AChE) inhibitors on the progression of Alzheimer's disease (AD). In order to define the profile of EEG changes during tacrine long-term treatment, for 12 months we followed 15 AD patients receiving an optimal individually tolerable dose. After 3 months theta global field power (GFP) was significantly reduced, and after 6 months both theta and delta GFP decreased. Theta GFP was still reduced after 12 months of treatment when compared to the baseline. Significant decreases in fast activities of beta 1 and beta 2 GFP were also observed. The untreated reference group (n = 10) did not show any significant changes in GFP after 12 months follow-up, although generators of theta activity had a significant shift towards posterior regions. These findings suggest that slowing in fast EEG frequencies during chronic treatment with AChE inhibitors may provide an early indicator of declining treatment efficiency.

[1]  J. Risberg,et al.  Oral tetrahydroaminoacridine treatment of Alzheimer's disease evaluated clinically and by regional cerebral blood flow and EEG. , 1993, Dementia.

[2]  B. Winblad,et al.  EEG regional changes during long‐term treatment with tetrahydroaminoacridine (THA) in Alzheimer's disease , 1993, Acta neurologica Scandinavica. Supplementum.

[3]  T Gasser,et al.  Quantitative EEG analysis in early onset Alzheimer's disease: correlations with severity, clinical characteristics, visual EEG and CCT. , 1994, Electroencephalography and clinical neurophysiology.

[4]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[5]  R F Woolson,et al.  A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. , 1992, The New England journal of medicine.

[6]  O Almkvist,et al.  Quantitative electroencephalography power and coherence in Alzheimer's disease and mild cognitive impairment. , 1996, Dementia.

[7]  G. Buzsáki,et al.  Nucleus basalis and thalamic control of neocortical activity in the freely moving rat , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[8]  Colin R. F. Monks,et al.  Three-dimensional segregation of supramolecular activation clusters in T cells , 1998, Nature.

[9]  M. Fioravanti,et al.  Effect of cholinergic and anticholinergic drugs on short-term memory in Alzheimer's dementia: a neuropsychological and computerized electroencephalographic study. , 1983, Clinical neuropharmacology.

[10]  Gastone G. Celesia,et al.  A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's Disease , 1994 .

[11]  V. Hachinski,et al.  Quantitative electroencephalographic correlates of cognitive decline in normal elderly subjects. , 1990, Archives of neurology.

[12]  Thomas Dierks,et al.  Topography of the quantitative electroencephalogram in dementia of the alzheimer type: Relation to severity of dementia , 1991, Psychiatry Research: Neuroimaging.

[13]  P. Riekkinen,et al.  Discrimination of Alzheimer patients responding to cholinesterase inhibitor therapy , 1993, Acta neurologica Scandinavica. Supplementum.

[14]  B. Winblad,et al.  Tacrine restores cholinergic nicotinic receptors and glucose metabolism in alzheimer patients as visualized by positron emission tomography , 1992, Neurobiology of Aging.

[15]  P. Solomon,et al.  A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group. , 1994, JAMA.

[16]  B. Sahakian,et al.  Tacrine in Alzheimer's disease , 1991, The Lancet.

[17]  L. Fitten,et al.  Quantitative EEG During a Double-Blind Trial of THA and Lecithin in Patients with Alzheimer's Disease , 1991, Journal of geriatric psychiatry and neurology.

[18]  M Farlow,et al.  A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group. , 1992, JAMA.

[19]  H. Soininen,et al.  Quantitative analysis of occipital EEG in different stages of Alzheimer's disease. , 1985, Electroencephalography and clinical neurophysiology.

[20]  D. Kaufer,et al.  Acute stress facilitates long-lasting changes in cholinergic gene expression , 1998, Nature.